IOV-4001

N/A

Report date: 2023/11/15 17:10:24

Base Information

Drug NameIOV-4001

Drug Alias NamePD-1 inactivated TIL therapy(Iovance Biotherapeutics)

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Tumor Infiltrating LymphocytesCell and gene therapy > Cell therapy > Donor > Autologous

Mechanisms of ActionT lymphocyte replacementsImmunologic cytotoxicity

TargetsNot applicable

Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungMelanomaNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesIovance Biotherapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesIovance Biotherapeutics Inc

Inactive CompaniesN/A

Active IndicationsCarcinoma, Non-Small-Cell LungMelanoma

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A